Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer

By Hensley Martee  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 51-52

Informa Healthcare

Access to resources Recommend Favorite

A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer

By Gore M.   Oza A.   Rustin G.   Malfetano J.   Calvert H.   Clarke-Pearson D.   Carmichael J.   Ross G.   Beckman R.A.   Fields S.Z.  

European Journal of Cancer, Vol. 38, Iss. 1, 2002-01 ,pp. : 57-63

Elsevier

Access to resources Recommend Favorite

The “predictive molecule targeted chemotherapy” for relapsed ovarian cancer—a pilot study

By Zhao Xiaodong   Zhang Yi   Yang Li   He Shurong  

The Chinese-German Journal of Clinical Oncology, Vol. 5, Iss. 5, 2006-10 ,pp. : 372-375

Springer Publishing Company

Access to resources Recommend Favorite

Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?

By  

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 117-119

Informa Healthcare

Access to resources Recommend Favorite

Clinical study of Shenqi Fuzheng injection decreasing side-effects of chemotherapy for patients with ovarian epithelial cancer

By Zhang Yu   Wan Jing   Yang Yuebo   Li Xiaomao  

The Chinese-German Journal of Clinical Oncology, Vol. 12, Iss. 11, 2013-11 ,pp. : 537-539

Springer Publishing Company

Access to resources Recommend Favorite